{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T03:09:15Z","timestamp":1772248155321,"version":"3.50.1"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>\n                    <jats:bold>Objective:<\/jats:bold>\n                    To assess the variations of the blood levels of immunoglobulins (Ig) in septic shock patients treated with an Ig preparation enriched in IgM and IgA (eIg).\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Design:<\/jats:bold>\n                    The blood levels of Ig in survivors (S) and non-survivors (NS) of a group of septic shock patients were measured before the initial administration (D0) and 1 (D1), 4 (D4), and 7 (D7) days thereafter. The SAPS II score, the capillary permeability, the primary site of infection, the antibiotic appropriateness, and the outcome at 28 days were also assessed.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results:<\/jats:bold>\n                    In the interval D0\u2013D7, the IgM increased significantly only in the S while remained stable in NS; the IgA significantly increased in both groups; the IgG did not vary significantly in both groups. At D4, the capillary permeability significantly decreased in S but not in NS.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusions:<\/jats:bold>\n                    The kinetics of the different classes of Ig after eIg were different between S and NS. This could be related either to (a) different capillary permeability in the two groups or to (b) higher Ig consumption in NS. Further studies to confirm the benefits of eIg in the treatment of sepsis syndrome and to define the specific target population and the correct eIg dose are warranted.\n                  <\/jats:p>","DOI":"10.3389\/fmed.2021.605113","type":"journal-article","created":{"date-parts":[[2021,2,28]],"date-time":"2021-02-28T23:40:37Z","timestamp":1614555637000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Kinetics of Immunoglobulins in Septic Shock Patients Treated With an IgM- and IgA-Enriched Intravenous Preparation: An Observational Study"],"prefix":"10.3389","volume":"8","author":[{"given":"Giorgio","family":"Berlot","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice","family":"Scamperle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatiana","family":"Istrati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Dattola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Longo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonino","family":"Chillemi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Baronio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giada","family":"Quarantotto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Zanchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik","family":"Roman-Pognuz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mattia","family":"Bixio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ariella","family":"Tomasini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,3,1]]},"reference":[{"key":"B1","first-page":"559","article-title":"Intravenous immunoglobulin in septic shock: review of the mechanisms of action and meta-analysis of the clinical effectiveness","volume":"82","author":"Busani","year":"2016","journal-title":"Minerva Anestesiol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"193","DOI":"10.7326\/0003-4819-146-3-200702060-00009","article-title":"Meta-analysis: intravenous immunoglobulin in critically ill adult patients with sepsis","volume":"146","author":"Turgeon","year":"2007","journal-title":"Ann Intern Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13613-019-0501-3","article-title":"The clinical efficacy of intravenous IgM-enriched immunoglobulin (pentaglobin) in sepsis or septic shock: a meta-analysis with trial sequential analysis","volume":"9","author":"Cui","year":"2019","journal-title":"Ann Intensive Care."},{"key":"B4","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1097\/CCM.0000000000002255","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016","volume":"45","author":"Rhodes","year":"2017","journal-title":"Crit Care Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s13054-015-0793-0","article-title":"The original sins of clinical trials with intravenous immunoglobulins in sepsis","volume":"19","author":"Almansa","year":"2015","journal-title":"Crit Care."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1007\/s00134-014-3474-6","article-title":"Early therapy with IgM-enriched polyclonal immunoglobulin in patients with septic shock","volume":"40","author":"Cavazzuti","year":"2014","journal-title":"Intensive Care Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.cmi.2016.01.021","article-title":"Improving outcomes of severe infections by multidrug-resistant pathogens with polyclonal IgM-enriched immunoglobulins","volume":"22","author":"Giamarellos-Bourboulis","year":"2016","journal-title":"Clin Microbiol Infect."},{"key":"B8","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.jcrc.2005.03.003","article-title":"Cost-effectiveness of immunoglobulin M-enriched immunoglobulin (Pentaglobin) in the treatment of severe sepsis and septic shock","volume":"20","author":"Neilson","year":"2005","journal-title":"J Crit Care."},{"key":"B9","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1023\/A:1009899803032","article-title":"Structure and function of immunoglobulins","volume":"3","author":"Sp\u00e4th","year":"1999","journal-title":"Sepsis."},{"key":"B10","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1126\/science.aan6619","article-title":"Natural polyreactive IgA antibodies coat the intestinal microbiota","volume":"358","author":"Bunker","year":"2017","journal-title":"Science."},{"key":"B11","doi-asserted-by":"publisher","first-page":"16103","DOI":"10.1038\/nmicrobiol.2016.103","article-title":"High-affinity monoclonal IgA regulates gut microbiota and prevents colitis in mice","volume":"1","author":"Okai","year":"2016","journal-title":"Nat Microbiol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1038\/nri2849","article-title":"The importance of natural IgM: scavenger, protector and regulator","author":"Ehrenstein","year":"2010","journal-title":"Nat Rev Immunol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1046\/j.1399-3089.2003.00098.x","article-title":"Immunoglobulin M-enriched intravenous immunoglobulin inhibits classical pathway complement activation, but not bactericidal activity of human serum","volume":"11","author":"Walpen","year":"2004","journal-title":"Xenotransplantation."},{"key":"B14","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.it.2008.08.004","article-title":"Modulation of the cellular immune system by intravenous immunoglobulin","volume":"29","author":"Tha-In","year":"2008","journal-title":"Trends Immunol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.1016\/j.intimp.2011.08.024","article-title":"Assessment of plasmatic immunoglobulin G and M levels in septic shock patients","volume":"11","author":"Venet","year":"2011","journal-title":"Internat Immunoprharmacol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"R247","DOI":"10.1186\/cc13073","article-title":"Kinetics of circulating immunoglobulin M in sepsis: relationship with final outcome","volume":"17","author":"Giamarellos-Bourboulis","year":"2013","journal-title":"Crit Care."},{"key":"B17","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1097\/SHK.0b013e3181a2c0b2","article-title":"Gamma globulin levels in patients with community-acquired septic shock","volume":"32","author":"Taccone","year":"2009","journal-title":"Shock."},{"key":"B18","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA."},{"key":"B19","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s13613-018-0466-7","article-title":"Effects of the timing of administration of IgM- and IgA-enriched intravenous polyclonal immunoglobulins on the outcome of septic shock patients","volume":"8","author":"Berlot","year":"2018","journal-title":"Ann Intensive Care."},{"key":"B20","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.jcrc.2011.05.012","article-title":"Relationship between the timing of administration of IgM and IgA enriched immunoglobulins in patients with severe sepsis and septic shock and the outcome: a retrospective analysis","volume":"27","author":"Berlot","year":"2012","journal-title":"J Crit Care."},{"key":"B21","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s13613-017-0268-3","article-title":"The protective association of endogenous immunoglobulins against sepsis mortality is restricted to patients with moderate organ failure","volume":"7","author":"Martin-Loeches","year":"2017","journal-title":"Ann Intensive Care."},{"key":"B22","doi-asserted-by":"publisher","first-page":"S25","DOI":"10.1016\/j.ijantimicag.2015.10.013","article-title":"Endogenous immunoglobulins and sepsis: new perspectives for guiding replacement therapies","volume":"46","author":"Bermejo-Martin","year":"2015","journal-title":"Int J Antimicrob Agents."},{"key":"B23","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1097\/01.shk.0000370606.30525.21","article-title":"Gamma globulin levels in patients with community-acquired septic shock","volume":"33","author":"Myrianthefs","year":"2010","journal-title":"Shock."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1007\/s00134-015-3845-7","article-title":"Endogenous IgG hypogammaglobulinemia in critically ill adults with sepsis: systematic review and meta-analysis","volume":"41","author":"Shankar-Hari","year":"2015","journal-title":"Intensive Care Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1097\/CCM.0000000000002627","article-title":"Can concurrent abnormalities in free light chains and immunoglobulin concentrations identify a target population for immunoglobulin trials in sepsis?","volume":"45","author":"Shankar-Hari","year":"2017","journal-title":"Crit Care Med."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1110e7","DOI":"10.1016\/j.jcrc.2013.06.007","article-title":"Early levels of immunoglobulin M and natural killer cells predict outcome in nonseptic critically ill patients","volume":"28","author":"Ojeda-Andaluz","year":"2013","journal-title":"J Crit Care."},{"key":"B27","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1097\/01.CCM.0B013E3181611F62F","article-title":"Immunoglobulin G treatment of postcardiac surgery patients with score-identified severe systemic inflammatory response syndrome\u2013the ESSICS study","volume":"36","author":"Werdan","year":"2008","journal-title":"Crit Care Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1097\/00003246-199109000-00003","article-title":"Treatment of gram negative septic shock with immunoglobulin preparation: a prospective, randomized clinical trial","volume":"19","author":"Schedel","year":"1991","journal-title":"Crit Care Med"},{"key":"B29","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1097\/SHK.0000000000001010","article-title":"A novel combination of biomarkers to Herald the onset of sepsis prior to the manifestation of symptoms","volume":"49","author":"Dolin","year":"2018","journal-title":"Shock"},{"key":"B30","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.amjms.2016.02.029","article-title":"Serum procalcitonin for differential diagnosis of acute exacerbation and bacterial pneumonia in patients with interstitial lung disease","volume":"351","author":"Sim","year":"2016","journal-title":"Am J Med Sci"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1097\/CCM.0b013e31820eda29","article-title":"Is worsening multiple organ failure the cause of death in patients with severe sepsis?","volume":"39","author":"Vincent","year":"2011","journal-title":"Crit Care Med"},{"key":"B32","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1056\/NEJMcibr1007320","article-title":"Sepsis and endothelial permeability","volume":"363","author":"Lee","year":"2010","journal-title":"N Engl J Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1186\/2110-5820-2-S1-S1","article-title":"Fluid management in critically ill patients: the role of extravascular lung water, abdominal hypertension, capillary leak, and fluid balance","volume":"2","author":"Cordemans","year":"2012","journal-title":"Ann Intensive Care."},{"key":"B34","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s13613-020-00740-1","article-title":"Best-practice IgM and IgA-enriched immunoglobulin use in patients with sepsis","volume":"10","author":"Nierhaus","year":"2020","journal-title":"Ann Intensive Care."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.605113\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,28]],"date-time":"2021-02-28T23:40:40Z","timestamp":1614555640000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.605113\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,1]]},"references-count":34,"alternative-id":["10.3389\/fmed.2021.605113"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2021.605113","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.09.08.20189183","asserted-by":"object"}]},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,1]]},"article-number":"605113"}}